| Brian Vincent Viviano, DO | |
|
2010 W 38th St Uppr Level, Erie, PA 16508-2004 | |
| (814) 866-6835 | |
| (814) 866-6837 |
| Full Name | Brian Vincent Viviano |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 15 Years |
| Location | 2010 W 38th St Uppr Level, Erie, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497984512 | NPI | - | NPPES |
| 003151031 | Other | PA | HIGHMARK |
| P01637821 | Other | PA | RR MEDICARE |
| 1030065750001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | OS015368 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Millcreek Community Hospital | Erie, PA | Hospital |
| Lecom Health Corry Memorial Hospital | Corry, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Erie | 2769402783 | 46 |
| Corry Memorial Hospital Association | 3971581174 | 23 |
News Archive
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.
A well-done analysis by Chen WY et al, published in JAMA assesses the association of moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. The authors use prospectively collected data from the 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 follow ups.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.
To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling.
› Verified 3 days ago
| Entity Name | Medical Associates Of Erie |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649205816 PECOS PAC ID: 2769402783 Enrollment ID: O20051205000786 |
News Archive
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.
A well-done analysis by Chen WY et al, published in JAMA assesses the association of moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. The authors use prospectively collected data from the 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 follow ups.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.
To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling.
› Verified 3 days ago
| Entity Name | Corry Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1518411677 PECOS PAC ID: 3971581174 Enrollment ID: O20160928002194 |
News Archive
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.
A well-done analysis by Chen WY et al, published in JAMA assesses the association of moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. The authors use prospectively collected data from the 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 follow ups.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.
To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling.
› Verified 3 days ago
| Entity Name | Corry Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124406376 PECOS PAC ID: 3971581174 Enrollment ID: O20170727002362 |
News Archive
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.
A well-done analysis by Chen WY et al, published in JAMA assesses the association of moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. The authors use prospectively collected data from the 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 follow ups.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.
To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling.
› Verified 3 days ago
| Entity Name | Millcreek Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1568097939 PECOS PAC ID: 8426020173 Enrollment ID: O20200616000936 |
News Archive
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.
A well-done analysis by Chen WY et al, published in JAMA assesses the association of moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. The authors use prospectively collected data from the 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 follow ups.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.
To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling.
› Verified 3 days ago
| Entity Name | Millcreek Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1871128447 PECOS PAC ID: 8426020173 Enrollment ID: O20200616001909 |
News Archive
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.
A well-done analysis by Chen WY et al, published in JAMA assesses the association of moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. The authors use prospectively collected data from the 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 follow ups.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.
To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Vincent Viviano, DO 1 Lecom Pl, Erie, PA 16505-2571 Ph: () - | Brian Vincent Viviano, DO 2010 W 38th St Uppr Level, Erie, PA 16508-2004 Ph: (814) 866-6835 |
News Archive
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.
A well-done analysis by Chen WY et al, published in JAMA assesses the association of moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. The authors use prospectively collected data from the 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 follow ups.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.
To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling.
› Verified 3 days ago
Bushra Rizvi, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 300 State St Ste 103a, Suite 103a, Erie, PA 16507 Phone: 814-877-8540 | |
Debjit Saha, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 201 State St, Erie, PA 16550 Phone: 814-877-4922 Fax: 814-877-3622 | |
Mr. Pradeep Dayanand, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 2315 Myrtle St Ste 190, Erie, PA 16502 Phone: 814-453-7767 Fax: 814-454-6667 | |
Dr. James Pawlak Iii, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 5515 Peach St, Erie, PA 16509 Phone: 814-864-4031 | |
Dr. Theresa J Fryer, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 3317 Liberty St, Erie, PA 16508 Phone: 814-868-8531 Fax: 814-866-1439 | |
Mohamad Khaled Sabeh, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2315 Myrtle St Ste 190, Erie, PA 16502 Phone: 814-453-7767 Fax: 814-454-6667 | |
Dr. Edward C Clark, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 311 W 24th St, Suite 402, Erie, PA 16502 Phone: 814-453-6687 Fax: 814-456-4676 |